Scotland has some of the best health service data in the world. Few other countries have information which combines high quality data, consistency, national coverage and the ability to link data to allow patient based analysis and follow up. The Information Services Division (ISD) is a division of National Services Scotland, part of NHS Scotland. ISD provides health information, health intelligence, statistical services and advice that support the NHS in progressing quality improvement in health and care and facilitates robust planning and decision making.
What's New in ISD?
Mental Health Benchmarking Releases
Our Mental Health Benchmarking tools have been designed to support staff drive continuous improvement in the provision of mental health services in Scotland.
The Adult Mental Health Toolkit (for data up to 31 March 2013) contains information on performance of a range of measures from length of stay and readmissions to compulsory treatment orders and suicides. The latest CAMHS Benchmarking Toolkit and Dashboard (for data up to June 2014) contains information on the Child and Adolescent Mental Health Services (CAMHS) waiting times and workforce statistics.
[Added 9 September 2014]
Government Statistical Service - User Engagement Case Study
Our 'Taking Care of Scottish Health Statistics' event has just been featured in a user engagement case study on the Government Statistical Service website
[27 August 2014]
Welcome to myISD. This is a feature that allows you to personalise your homepage and keep all the parts of the website you use regularly in one easy to find place. You can sign up for the newsletters you like to see and set any preferences. You will need to fill in a simple form to register for myISD. That lets us see the features you use regularly so we can make the site better for you.
- 4,634,362 outpatients were seen at consultant clinics in 2013/14, 1,508,498 of which were new outpatients. The number of new outpatient attendances has increased by 13.0% from 2004/05 when there were 1,335,069 new outpatient attendances.
- The return to new ratio for outpatient attendances has reduced steadily over the last nine years from 2.4 in 2004/05 to 2.1 in 2013/14. This has resulted in a lower proportional increase in the total number of outpatients seen at consultant clinics.
- Improving efficiency, by reducing unneccesary return outpatient appointments and the number of patients who do not attend pre-arranged appointments (DNAs) continues to be a priority for NHS boards. The percentage of new appointments which patients did not attend (DNAs) in 2013/14 was 9.8%, a reduction of 0.4% from 10.2% in 2012/13 and 1.3% from 11.7 in 2004/05.
- The total number of hospital discharge episodes from acute specialties in 2013/14 was 1,524,917; an increase of 22.9% from 1,240,311 in 2004/05. The rate of increase has fluctuated over the years. It peaked between 2007/08 and 2008/09 when there was an increase of 4.1% and reached a low of 0.3% the following year. More recently, figures show that over the last year number of disharge episodes increased by 3.0%.
- In 2013/14 there were 554,893 non-routine (emergency) inpatient discharges; an increase of 15.3% from 481,260 in 2004/05. The rate of increase peaked between 2006/07 and 2007/08 when the number of non-routine discharges increased by 4.2% More recently, figures show that over the last year rate of increase has slowed to 0.6%.
- The average number of available staffed beds in acute specialties was recorded as 16,315 in the financial year 2013/14. This is a reduction of 7.1% from 17,559 beds in 2004/05.
- Across Scotland the rate of emergency bed days per 1,000 patients aged 75 and over reduced by 13.7% from 5,420 in 2009/10 to a provisional 4,677 in 2013/14.
- The average QOF payment to a GMS practice for 2013/14 was £130,600. This is down from £142,000 in 2012/13. This decrease was due to a number of reasons, notably the reduction in total available QOF points from 1,000 to 923 and was offset by changes to other (non-QOF) parts of the GP contract.
- The average number of points achieved by GMS practices was 901 out of a maximum of 923 (97.6%). This is a similarly high level of achievement to previous years.
- The largest increase in achievement for a group of clinical indicators between 2012/13 and 2013/14 was in the osteoporosis indicator group which was introduced in 2012/13. This increased from 84.7% to 91.9%, a difference of 7.2 percentage points.
- The largest decrease in achievement for a group of clinical indicators between 2012/13 and 2013/14 was in the cardiovascular disease indicator group. This decreased from 96.5% to 91.9%, a difference of 4.6 percentage points, principally due to the addition of a new indicator to the group for 2013/14.
- In 2013/14 a new indicator group for Rheumatoid Arthritis has been included in QOF with an overall achievement of 97.6% and QOF prevalence rate of 0.6%.
- Based on achievement over the three financial year period, 13 of the 14 NHS Boards in Scotland met their smoking cessation HEAT target.
- The total number of self-reported quits at one month after quit date during the period 1 April 2011 to 31 March 2014 was 124,734 (38%), exceeding the target by 56%.
- There were 70,162 (36%) self-reported quits at one month after quit date in the 40% most deprived within-board Scottish Index of Multiple Deprivation (SIMD) areas, exceeding the target number set (48,000) by 45%.
- There were 322,285 quit attempts made with the help of NHS smoking cessation services in Scotland between 1 April 2011 and 31 March 2014.
- Of these, 195,355 (59%) were made in the 40% most deprived within-board SIMD 2009 areas in Scotland.
- This publication is a technical report that is designed to be used as a resource by health boards. The heart disease indicators have the potential to inform improvements in the quality of care and patient experience.
- For the majority of the 18 indicators within this publication, the data points for all health boards show variation that is within expected boundaries relative to the Scottish average.
- Six of the indicators contain data points for some health boards that show variation outside the expected boundaries. These may be worthy of further consideration using local expert knowledge. Although there are some outliers, the majority of health boards lie within the expected boundaries for these indicators.
- The six indicators that show variation outside the expected boundaries relate to the average length of stay in hospital for admissions involving heart attack, angioplasty and coronary artery bypass grafts.
- HPV immunisation uptake rates in Scotland remain high.
- 81.4% of girls in S2 in school year 2013/14 had completed their course of three HPV immunisations by the end of the school year. At the time of reporting, 91.7% had received two doses and 93.6% had received one dose. These uptake rates are similar to the equivalent reported rates for girls in S2 in the previous school year.
- Data for the first five years of the HPV immunisation programme show that a number of girls in S2 complete their immunisation course after the school year in which they were first offered the vaccine. Uptake rates for girls in S2 during school year 2013/14 are expected to increase as girls complete their immunisation course in school year 2014/15. Updated uptake rates for these girls ‘one year later’ will be published in September 2015.
- For girls who were in S2 during school year 2012/13, one year later data shows uptake rates increased to 91.4% for all three doses, 93.4% for two doses and 94.4% for one dose by the end of school year 2013/14.
- The total uptake of very long acting methods (the contraceptive implant, IUDs (the coil) and Mirena (IUS)) in Scotland increased slightly from 61.9 per 1,000 women aged 15-49 in 2012/13 to 62.1 per 1,000 women in 2013/14.
- The contraceptive implant (Nexplanon) is the most popular method of LARC and uptake in 2013/14 shows it has continued to rise.
- Use of Mirena Intrauterine System (IUS) has continued to rise.
- IUDs (the coil) remain the least utilised and have shown a slight decrease in the dispensing rate from last year.
- Uptake of these very long acting or ‘lasting’ methods has increased in eight NHS boards.
- Dispensing of antipsychotics, antidepressants, drugs for ADHD and drugs for dementia has been steadily increasing over the past ten years; dementia also showing a sharp increase in recent years. Dispensing of hypnotics and anxiolytics has remained stable in the past ten years.
- Increased dispensing of drugs classified as antidepressants should be interpreted with caution; a notable proportion of these drugs are prescribed at low dose for conditions other than depression.
- Trends in volume tend to be consistent with trends in patient counts and Defined Daily Doses over time.
- Costs do not necessarily follow the same patterns over time as volumes of mental health drugs dispensed and can show significant fluctuation; the reasons vary for different types of mental health drugs, but in general sharp increases in cost are usually due to drugs being in short supply and sharp decreases are usually due to drugs coming out of patent.
- All of the mental health drugs considered in this report show a consistent pattern of increasing volume dispensed with increasing patient deprivation. For elderly patient dispensed dementia drugs, this pattern is less pronounced, but still evident.
- Dispensing of most mental health drugs peaks for patients in middle age and is consistently higher for females, apart from dementia drugs which are predominantly dispensed to elderly patients and drugs for ADHD which are dispensed mainly to adolescent males.
- The gross total payments to Scottish dispensing contractors increased by £7.2 million (2.6%) between quarter 1 of 2013/14 and quarter 1 of 2014/15.
- Dispensing of smoking cessation products decreased in 2013/14 for the first time since 2006/07. There were 76,942 (12.3%) fewer items than in 2012/13.
- Gross ingredient costs decreased in 2012/13 for the first time since 2006/07. This decrease continued in 2013/14 with a reduction of £2,153,157 (15.0%) from last year.
- The overall average cost per item continues to decrease and is now £22.35, down from £23.04 in 2012/13.
- NHS Ayrshire and Arran was the only NHS Board to show an increase (8.0%) in the number of smoking cessation product items dispensed in 2013/14.
- Nicotine continues to be the most prescribed product, making up 85.7% of all smoking cessation products in 2013/14.
- The 62 Day Standard is that 95% of patients urgently referred with a suspicion of cancer will wait a maximum of 62 days from referral to first cancer treatment.
- In the quarter ending 30 June 2014, 92.9% of patients started treatment within 62 days of urgent referral with suspicion of cancer. This compares to 91.5% in the period January – March 2014.
- In the quarter ending 30 June 2014, the 62-day standard was not met for nine NHS Boards: NHS Grampian, NHS Highland, NHS Shetland, NHS Tayside, NHS Western Isles, NHS Dumfries and Galloway, NHS Fife, NHS Ayrshire and Arran and NHS Greater Glasgow and Clyde.
- The 31 Day Standard is that 95% of all patients, regardless of route of referral, will wait a maximum of 31 days from decision to treat to first cancer treatment.
- In the quarter ending 30 June 2014, 96.3% of patients started treatment within 31 days of decision to treat, regardless of the route of referral. This compares to 96.2% in the period January – March 2014.
- In the quarter ending 30 June 2014, the 31-day standard was not met for two NHS Boards: NHS Grampian and NHS Greater Glasgow and Clyde.
- In April-June 2014, 96.8% of the 11,122 people who started their first drug or alcohol treatment waited 3 weeks or less (HEAT standard), compared to 96.1% in the previous quarter.
- 97.5% of the 7,315 people who started alcohol treatment between April - June 2014 waited 3 weeks or less, compared to 97.0% in the previous quarter.
- 95.5% of the 3,807 people who attended an appointment for drug treatment waited 3 weeks or less, compared to 94.4% in the previous quarter.
- Of the 2,920 people who were still waiting to start drug or alcohol treatment, 43 people, or 1.5%, had waited more than 6 weeks at the end of June 2014, compared to 75 people, or 2.4% in the previous quarter.
- This publication does not include complete data for June 2014 for NHS Lothian due to issues moving to a new Patient Management System (PMS).
Vaccination programmes for children in Scotland aim both to protect the individual from many serious infectious diseases and to prevent the spread within the wider population. This publication provides a quarterly update of immunisation uptake rates for children at 12 months, 24 months, five years and six years of age, by NHS Board and Community Health Partnership for the quarter ending 30 June 2014. The publication also includes provisional figures on rotavirus immunisation for children reaching six months of age in the quarter ending 30 June 2014.
- On the 31st March 2014, 1698 people had been reported to the MS Register; 421 with a date of diagnosis in 2010, 389 in 2011, 437 in 2012, and 451 in 2013.
- Over the four year time period 20 people (1%) declined contact with an MS nurse specialist.
- In 2013, more than twice as many women (325, 72%) as men (126, 28%) were diagnosed with MS.
- 57% of people newly diagnosed with MS in 2013 had contact with an MS nurse specialist within two weeks of diagnosis. This is an 11% improvement on 2012.
- 7% of people were supported by an MS Nurse specialist prior to being given a confirmed diagnosis of MS in 2013.
- In 2013, nationally the time response within two weeks was very effective (86%) once the MS Nurse specialist received patients referral.
- Delays in referral to MS nurse and delays in MS nurse receiving referral continue to be problematic.
- The majority (83%) of people diagnosed in 2013 were referred to an MS nurse specialist within 2 weeks of receiving a confirmed diagnosis; however 11% of people waited over 6 weeks before being referred. This is a 4% improvement on 2012.
- The majority (84%) of referrals to an MS nurse specialist in 2013 were received within 2 weeks; however 13% of referrals took between 2 and 4 weeks before being received by an MS nurse. This is a 3% improvement on 2012.
- Quality feedback reports, targeting individual steps in the referral process, are sent quarterly to MS clinical Leads and MS Nurse Specialists in order to identify delays and target solutions at a local level.